ABSTRACT: Pig production is a commodity business, which makes it a cost-driven business. Pig producers and their advisors are appropriately reluctant to adopt technologies without confi dence that improved production will more than pay for the cost of the technology. Physiological effects of technologies targeting gut sensory pathways must translate to demonstrably improved health and/or productive performance if they are to be adopted. The types and degrees of stressors experienced by pigs in commercial production vary widely and often differ from those in research herds, and those variations infl uence their productive responses to nutritional and health technologies. Pigs are most vulnerable to disease soon after weaning, and the diets fed to pigs at that time are more expensive and offered in much smaller amounts than those fed later in life. Those factors make it easier to justify expensive dietary technologies for young pigs than for older ones. New developments in gut chemosensing appear important, but their practical application is not yet clear. We suggest investigation of the potential to connect chemical detection by the gut to pig productivity and/or effi ciency through these mechanisms: 1) trophic effects on the intestines, which lead to improved enteric health or enhanced nutrient digestion and absorption, 2) enhanced barrier function in the intestinal mucosa, 3) increased feed intake, 4) enhanced insulin secretion and sensitivity, which may be especially useful in lactating sows to improve subsequent reproduction, and 5) other signals triggered by products of enteric fermentation, possibly short-chain fatty acids, that may infl uence gut integrity, feed intake, and reproductive function. Each of these mechanisms relates to a practical issue in pig production. Practical application would likely be achieved through dietary changes, but separate management factors, drugs, or other interventions may also be developed.
INTRODUCTION
The purpose of this paper is to identify potential opportunities for exploiting knowledge of chemical sensing by the gastrointestinal (GI) tract of pigs in developing new technologies to improve pig production or health. To this end, gut chemosensing is herein considered to be accomplished by a network of G protein-coupled receptors (GPCR) that are exposed to the luminal environment and recognize ingested nutrients and other chemicals. As a consequence, they initiate a cascade of signals that convey information to intestinal cells and brain centers that ultimately affect physiological and metabolic responses both locally and extra-intestinally. The list is not intended to be exhaustive but to identify a few topics that may be productive areas of research. The items are mostly rather broad, not specifi c. In line with the above defi nition, they take the general form of a cascade of events starting with a receptor, which triggers a mediator, resulting in a useful outcome. The mechanisms for gut chemical sensing and the mediators are comprehensively described in the preceding papers in this series (Liou, 2012; Mace and Marshall, 2012; Bannai and Torri, 2013; Burrin et al., 2013; Kaji et al., 2013; Steinert et al., 2013) .
CONTEXT
Swine products occupy an important position in human food consumption. The need to continue to increase food production with the limited resources of the earth places the onus squarely on the swine industry to increase both effi ciency and production. This need creates a strong demand for new swine production technologies. To this end, the global swine industry has aggressively adopted nutritional, genetic, management, and health technologies. Powerful health technologies including age segregation, all-in/all-out pig fl ow, biosecurity measures, sanitation, vaccination, and depopulation-repopulation are routinely used in the swine industry to protect pigs from disease. In addition, many feed ingredients or additives are now available for use in improving pig productivity and health, often by either altering microbial populations in the GI tract or infl uencing the immune system to maintain pig health.
On the other side, swine production is a commodity business, which makes it a cost-driven business. Pig producers and their advisors are appropriately reluctant to adopt technologies without confi dence that improved production will more than pay for the cost of the technology. Therefore, physiological effects of technologies targeting gut sensory pathways must translate to demonstrably improved health and/or productive performance if they are to be adopted. Evaluation of such technologies is complicated by the fact that the types and degrees of stressors experienced by pigs in commercial production vary widely and often differ from those in research herds; benefi ts of new technologies may be larger in practice than in research herds.
The immediate postweaning period is one of the most challenging and critical stages in swine production because during this period pigs are especially vulnerable to disease. Weaning affects behavior, environment, disease, immunity, and nutrition. The diets fed to young pigs are more expensive and consumed in much smaller amounts than those fed later in life. Those factors make it easier to justify expensive dietary technologies for young pigs than for older ones.
PROPOSED AREAS FOR EXPLORATION
We suggest investigation of the potential to connect chemical detection by the gut to pig productivity and/or effi ciency through these mechanisms: 1) trophic effects on the intestines that may lead to improved enteric health or enhanced nutrient digestion and absorption, 2) enhanced barrier function in the intestinal mucosa, 3) increased feed intake, 4) enhanced insulin secretion and sensitivity, which may be especially useful in lactating sows to improve subsequent reproduction, and 5) other signals triggered by products of enteric fermentation, possibly short-chain fatty acids (SCFA), that may infl uence reproductive function and other aspects of productivity.
Trophic Effects on the Intestines
Weaning prompts predictable changes in the small intestinal structure and function, including villous atrophy and crypt hyperplasia. These changes are associated with poor pig performance, presumably because they decrease the digestive and absorptive capacity of the small intestine (Hampson, 1986; Pluske et al., 1996a,b; Gu et al., 2002) . It therefore seems likely that enhancement of the growth of the intestinal mucosa, in opposition to the detrimental effects of weaning, would be benefi cial. Indeed, observations in parenterally fed pigs and other models of intestinal dysfunction (Burrin et al., 2003; Dubé and Brubaker, 2007) support that notion, showing benefi ts from promoting mucosal growth.
Glucagon-like peptide (GLP)-2, which is cosecreted with GLP-1 by the enteroendocrine L cells, can have potent and specifi c trophic effects on the GI tract that are characterized grossly by increased tissue mass and mucosal thickness and morphologically by increased villus height and crypt depth (Drucker et al., 1996; Lovshin and Drucker, 2000; Burrin et al., 2001) . The mechanisms through which GLP-2 mediates these effects include suppression of apoptosis and proteolysis (Burrin et al., 2000) and stimulation of cell proliferation (Tsai et al., 1997) , and the results include increased nutrient absorption, improved gut barrier function, and attenuation of intestinal mucosal injury (Estall and Drucker, 2006; Akiba and Kaunitz, 2011) . Collectively, these effects appear counter to the effects of weaning or of enteric disease on the gut, so they may be important in limiting the detrimental effects of weaning on gut function (Burrin et al., 2003) .
In the intestine, GLP-1 and -2 are secreted in response to nutritional, hormonal, and neural stimuli (Burrin et al., 2003) . As reviewed in preceding papers from this symposium, a number of nonnutritive compounds, including noncaloric sweeteners, umami tastants, and bile acids, have recently emerged as potent activators of the intestinal release of these peptides (Mace and Marshall, 2012; Burrin et al., 2013; Kaji et al., 2013) . Dietary sugars and nonnutritive sweeteners are primarily sensed by the sweet taste receptor, a GPCR that is functionally present as the heterodimer T1R2+T1R3 in taste buds within the oral cavity of most mammals (Treesukosol et al., 2011) . This receptor is also expressed in distal parts of the GI tract, where its activation by glucose and noncaloric sweeteners may stimulate the secretion of GLP-1 and other gut peptides in pigs (Shirazi-Beechey et al., 2011; Mace and Marshall, 2012) ; however, a number of studies with rodents and humans were unable to confi rm such a response (Brown and Rother, 2012) . The inconsistent results encourage further research to evaluate the potential role of agonists of the porcine T1R2+T1R3 in promoting or sustaining intestinal growth at weaning.
A separate mechanism connecting chemical sensing to trophic effects on the gut involves a number of AA sensors, most notably some members of the metabotropic glutamate receptor (mGluR) family and the umami taste receptor T1R1+T1R3, which are diffusely expressed in the GI tract to sense luminal AA (Wellendorph et al., 2009 ). In the intestines of rats, activation of the umami receptor by Glu triggers the release of GLP-2 (Wang et al., 2011) . The umami receptor is also present in the GI tract of pigs and its degree of expression increases remarkably in the small intestine after weaning and with the ingestion of protein-defi cient diets (Tedó et al., 2011a,c) . Coincidentally, supplementation of Gln or Glu in diets has been reported to prevent intestinal atrophy and improve gut integrity in weaned pigs ( Fig. 1 ; Wu et al., 1996; Liu et al., 2002; Yi et al., 2005; Wang et al., 2008; Hsu et al., 2010; Vermeulen et al., 2011) .
The impacts of Gln and Glu are complex. Intestinal growth is stimulated by growth factor release (i.e., GLP-2 followed by IGF-1 or epidermal growth factor), but it requires energy and nutrients to support proliferation of enterocytes. Luminal Glu, rather than glucose, is a good energy source for enterocytes, so luminal Glu has dual benefi ts for small intestinal epithelium: intestinotrophic GLP-2 release and epithelial energy supply. Correspondingly, circulating Gln and luminal SCFA are the energy source for colonocytes (Reeds et al., 1996; Blachier et al., 2009) . In some cases these AA and other agonists of the porcine T1R1+T1R3 also improve growth performance (Wu et al., 1996; Liu et al., 2002; Hsu et al., 2010; Tedó et al., 2011b) . Some of these benefi ts, however, may be mediated through mechanisms other than trophic effects on the gut, such as strengthened intestinal barrier function (Hsu et al., 2010) .
Seminal studies in mice revealed that bile acids induce the secretion of GLP-1 by signaling through the G protein-coupled bile acid receptor 1 (TGR5), which is a bile acid-sensing GPCR expressed in the luminal surface of enteroendocrine L cells (Katsuma et al., 2005; Burrin et al., 2013) . Considering that GLP-1 and -2 are co-secreted, these fi ndings lead to the hypothesis that activating the bile acid signaling cascade may induce GLP-2 secretion and thereby ameliorate intestinal dysfunction that typically affects piglets fed parenterally (Jain et al., 2012) or weaned at early age (Ipharraguerre et al., 2012) . Two studies confi rmed that chenodeoxycholic acid (CDCA), a primary bile acid, potently stimulates GLP-2 release in newborn (Jain et al., 2012) and weanling (Ipharraguerre et al., 2012) piglets. Provision of CDCA virtually restored intestinal mucosal growth, presumably by increasing GLP-2, during the neonatal phase but not after weaning.
These results, along with previous fi ndings indicating that the administration of GLP-2 at pharmacological doses to piglets had only minor effects on weaninginduced gut atrophy (Le Huerou-Luron et al., 2002) , show a lack of clarity about the practical effects of increased secretion of GLP-2. It is well established that increasing GLP-2 supports intestinal growth in models of intestinal injury (Estall and Drucker, 2006) and in neonatal pigs (Burrin et al., 2003; Jain et al., 2012) , but it is unclear that similar effects are attainable in newly weaned and older pigs.
Enhanced Barrier Function
The gut barrier is critical for reducing exposure to toxins and pathogens that may be present in the intestinal lumen. In this review, we focus only on the physical diffusion barriers, including tight junctions and mucus.
The cells of the intestinal epithelium are connected by tight junctions that help to block paracellular transfer of materials from the intestinal lumen into the body. Increased expression of the proteins that make up the tight junctions may strengthen the gut barrier and improve animal health. Stresses, such as heat (Hall et al., 2001; Lambert et al., 2002) and bacterial antigens (Pérez-Bosque et al., 2006) , weaken the tight junctions, allowing toxins and pathogens present in the intestinal lumen to enter the body tissues.
Dietary supplementation with spray-dried animal plasma has been described to improve intestinal mucosal barrier function, as indicated by reduced dextran fl ux, increased expression of 2 tight junction proteins, β-catenin and zonula occludens-1, and reduced pro-infl ammatory cytokines in the intestinal mucosa in weaned rats challenged with a bacterial antigen (Pérez-Bosque et al., 2006) . Peace et al. (2011) have observed that feeding spray-dried plasma to weaned pigs ameliorated intestinal barrier dysfunction, as indicated by increased claudin-1 localization and expression in the intestine and decreased ileal permeability. These effects may contribute to the widely recognized benefi ts of spray-dried plasma on pig growth performance (Coffey and Cromwell, 2001; Van Dijk et al., 2001) . Such effects of spray-dried plasma may be mediated through chemical sensing although the mechanisms have not been clearly identifi ed.
In vitro studies have shown that Gln can also reduce hyperpermeability, probably by strengthening tight junctions (Kouznetsova et al., 1999; Li et al., 2004; Vermeulen et al., 2011) . This effect might have been mediated by increased secretion of GLP-2 in response to the detection of Gln by the intestinal T1R1+T1R3 receptor. This is because GLP-2 treatment has been shown to reduce the permeability of the intestine to macromolecules, decrease bacterial translocation, and suppress the local expression of pro-infl ammatory cytokines (Alavi et al., 2000; Benjamin et al., 2000) .
Very recent reports demonstrate that bile acids also play a role in regulating the barrier function of the intestinal mucosae. Addition of the primary bile acid, CDCA, to the diet of early-weaned piglets reduced the intestinal permeability to lactulose and Co-EDTA (van der Meer et al., 2012) . This effect could have been mediated by GLP-2 given that the intragastric administration of CDCA to weanling pigs strongly increased circulating GLP-2 concentration in a separate study (Ipharraguerre et al., 2012) . The underlying molecular mechanism, however, appears not to involve changes in the expression of tight junction proteins because the infusion of CDCA did not affect the intestinal abundance of mRNA encoding claudin-2, occludin, and zonula occludens-1 (I. R. Ipharraguerre, unpublished data; Fig. 2 ).
Gut mucus, anchored by mucin proteins secreted by goblet cells, forms a protective layer above the surface of the epithelium to prevent the adherence of luminal bacteria and provide lubrication for propulsion of gut contents (Gareau et al., 2007) . Amino acid-sensing receptors expressed in the GI tract, especially the umami receptor and mGluR1, participate in regulating secretion of mucin and bicarbonate . Intestinal perfusion with Glu augments the secretion of mucin and bicarbonate in rats ( Fig. 3 ; Akiba et al., 2009 ), a response that is partly mediated by GLP-2 release from Glu signaling through the umami receptor (Wang et al., 2011) . A similar mechanism might operate to facilitate the impact of Thr on mucin secretion in pigs (Law et al., 2006 ) because this AA is recognized by the porcine T1R1+T1R3 (Roura et al., 2008) . As discussed subsequently, increased mucin secretion triggered by nonstarch polysaccharides, including galactooligosaccharide, fructooligosacchride, and arabinoxylan (Morel et al., 2003; Tanabe et al., 2006; Leforestier et al., 2009) , may involve intestinal signaling pathways activated by their end product of enteric fermentation.
Impacts on Feed Intake
When the lower intestine, distal to the primary absorptive area, senses a high concentration of nutrients, the body interprets that digesta particles were in the more proximal areas for too little time to allow thorough digestion and absorption. It then activates a process to slow the rate of passage of digesta, a distal to proximal feedback mechanism often called the "ileal brake" (Read et al., 1984; Spiller et al., 1984 Spiller et al., , 1988 . The resulting reduction of the rate of intestinal transit in turn reduces feed intake (Van Citters and Lin, 1999; Maljaars et al., 2008) .
Several peptides secreted by L-cells in the ileum and colon are considered as the mediators for the ileal brake, including peptide YY (PYY), GLP-1, and GLP-2 (Van Citters and Lin, 1999; Maljaars et al., 2008; Steinert et al., 2013) . The sweet and bitter taste receptors or tastespecifi c GPCR expressed in the L-cells appear to sense various nutrients in the lumen and induce the secretion of these peptides that activate enteral afferent nerves or distal targets by entering the circulation (Cummings and Overduin, 2007; Sternini et al., 2008; deFonseka and Kaunitz, 2009; Liou, 2012) . Peptide YY was confi rmed as the primary mediator of the fat-induced ileal brake (Pironi et al., 1993; Lin et al., 1996 Lin et al., , 1997 because fat Figure 2 . The intragastric administration of the primary bile acid chenodeoxycholic acid to early-weaned piglets did not affect (P > 0.13) the mRNA abundance of genes encoding the tight junction proteins claudin-2, occludin, and zonula occludens-1 on d 6 after weaning (27 d of age). Data are mRNA abundance expressed relative to the control group that received intragastric infusion of water (I. R. Ipharraguerre, unpublished data).
in the distal gut directly stimulates the release of this peptide (Aponte et al., 1988) . Glucagon-like peptide-1 is released primarily in response to carbohydrate and fat; its actions include inhibition of gastroduodenal motility (Schirra et al., 2006) , relaxation of the proximal stomach (Schirra et al., 2002) , suppression of gastric acid secretion (Schjoldager et al., 1989; Layer et al., 1995; Wettergren et al., 1997) , and regulation of endocrine pancreatic secretion (Schirra et al., 2006) . The intravenous infusion of GLP-2 in insulin-induced hypoglycemic pigs dose-dependently inhibited antral motility, indicating that intestinal GLP-2 may operate as 1 of the hormonal transmitters of the ileal brake effect (Wøjdemann et al., 1998) . This proposition, however, has been questioned because peripheral administration of GLP-2 at pharmacological doses did not reduce intake or hunger in a number of studies (Burrin et al., 2003; Estall and Drucker, 2006) .
A high level of animal productivity requires a high level of feed intake. Therefore, the target for the pig industry is to interrupt or attenuate the cascade of events that starts with sensing of nutrients in the lower intestine and results in reduced feed intake. In other words, the pig industry needs to fi nd ways to partially release the ileal brake. This need imposes a diffi cult challenge because it requires suppressing the release of GLP-1 and other anorexigenic signals without limiting the secretion of the co-secreted GLP-2 and other mediators of gut mucosal growth and barrier function. Simultaneously, however, gut chemosensors are implicated in enhancing the reward value of nutrients by conveying viscerosensory signals generated by luminal nutrients to brain centers that control hunger and hedonism. In this way, gut-brain signaling may stimulate appetite for fl avors associated with these nutrients, which in turn can increase feed intake even beyond homeostatic need. At the present time, however, the involvement of gut peptides in forming part of the postoral reward mechanism remains elusive (Sclafani and Ackroff, 2012) . Regardless of this limitation, it seems that the gut chemosensory system has a biphasic role by triggering some signals that induce satiety and others that stimulate appetite. This latter role might have contributed to increased feed intake and BW gain of newly weaned pigs fed diets containing sensory additives, such as high intensity sweeteners (Schlegel and Hall, 2006; Sterk et al., 2008) or umami tastants (Roura et al., 2008; Tedó et al., 2011b) .
Enhanced Insulin Secretion and Sensitivity
Insulin is an anabolic hormone central to body function and is, therefore, critical to productivity of animals. As reviewed in preceding papers of this symposium (Liou, 2012; Steinert et al., 2013) , ingested nutrients, in particular glucose, stimulate enteroendocrine cells to secrete glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. These gut peptides, jointly known as incretin hormones, greatly contribute to glucose homeostasis by inducing insulin secretion in a glucose-dependent manner and maintaining insulin sensitivity in peripheral tissues (Kreymann et al., 1987; Nauck et al., 1989; Rask et al., 2001 ). Furthermore, both peptides stimulate the proliferation and survival of pancreatic β-cells as well as their capacity to synthesize insulin (Holst and McGill, 2012) . In very recent years, incretin hormones along with the gut signaling pathways that control their secretion have become the target of numerous investigations aiming to develop therapies for managing glycemia in humans with type 2 diabetes mellitus. These research efforts have led to the discovery of potent agonists of GPCR expressed in L cells that enhance insulin release, reduce insulin resistance, and decrease blood glucose concentration via increased secretion of intestinal GLP-1 (Holst and McGill, 2012) . Interestingly, a synthetic agonist of the bile acid-sensing receptor TGR5 has been proved effective as a GLP-1-based therapy for regulating glycemia in mice and 2 later studies have shown that enteral bile acid administration to pigs strongly augments the secretion of endogenous GLP-1 (Jain et al., 2012) . It seems reasonable to propose, therefore, that a similar approach could be applied to attempt to control insulin secretion and tissue sensitivity in pigs and other animals. Such an approach could have major implications for animal growth, but the emphasis herein is on reproduction.
Several lines of evidence show the close connection of insulin to pig reproductive function (Pettigrew and Tokach, 1993) . Key reproductive organs, including the hypothalamus, pituitary gland, and ovary, have insulin receptors, and in vitro data show important effects of insulin on their reproductive function. Injections of insulin into sows improved their reproductive performance (Cox et al., 1987) . Circulating insulin concentrations are positively related to components of reproductive activity, such as secretion of LH ( Fig. 4 ; Tokach et al., 1992; Koketsu et al., 1996) . Benefi cial effects of supplemental dietary chromium (Evock-Clover et al., 1993; Lindemann et al., 1995) are almost certainly mediated through an increase in insulin sensitivity. Finally, an increase in feed intake increases insulin release, and the positive relationship between feed intake of sows during lactation and their subsequent reproductive performance is well documented (Aherne and Kirkwood, 1985) . Collectively, this evidence indicates that increased insulin release or sensitivity of tissues would improve reproductive performance of sows.
Other Signals Triggered by Enteric Fermentation
Dietary fi ber passes through the stomach and upper intestine undigested but is then subject to fermentation by the microbiota resident in the lower gut, resulting in production of SCFA. Enteroendocrine cells can sense SCFA via their surface SCFA receptor, G proteincoupled receptor 41 and GPR43, and then release PYY (Karaki et al., 2006) and GLP-1 (Tolhurst et al., 2012) . Because GLP are co-secreted by intestinal L-cells in a 1 to 1 ratio and are cleared from circulation by similar mechanisms (Estall and Drucker, 2006) , it is likely that SCFA-mediated activation of intestinal GPCR also triggers intestinal release of GLP-2. In fact, SCFA improved intestinal adaptation in neonatal piglets through a mechanism that involves increased circulating GLP-2 (Bartholome et al., 2004) . In line with the previous discussion, targeting enteric fermentation may prove helpful to improve gut mucosal integrity in stress-challenged pigs and modulate insulin secretion sensitivity in sows through GLP-mediated mechanisms.
The receptors for many gut hormones, such as cholecystokinin, PYY, ghrelin, leptin, GLP-1, and GLP-2, have been found to exist on the neurons in the brain (Raybould, 2010) . As described previously, the central nervous system is able to integrate and interpret these hormonal signals in response to different mechanical and chemical stimulation (Strader and Woods, 2005; Reimann et al., 2012; Sclafani and Ackroff, 2012) . These signals may impact many aspects of pig production, but we highlight here potential effects of dietary fi ber on reproduction, presumably mediated through sensing of the products of fermentation in the gut, transmitted through mediators to the brain, and impacts of those mediators on the reproductive function of the hypothalamus.
Applied studies indicate that feeding fi ber to sows improves their reproductive performance, as reviewed by Reese et al. (2008) . Many individual studies were not powerful enough to show the benefi ts statistically, but the meta-analysis of the entire body of evidence conducted by Reese et al. (2008) persuasively argues that dietary fi ber improves reproduction. The benefi t appears to occur only when fi ber is fed before breeding, such as when it is fed during successive reproductive cycles. In such multiple-parity studies, including fi ber in the gestation diet did not alter litter size in the fi rst litter (i.e., numeric increase of 0.1 pigs born alive per litter), but it did increase litter size in the second and third parities by 0.9 and 0.5 pigs, respectively. Current knowledge supports practical application of feeding fi ber, but a more sophisticated approach to timing and types of fi ber awaits fuller understanding of the physiological mechanisms, including chemical sensing by the GI tract.
SUMMARY AND CONCLUSIONS
There appear to be practical prospects for improving the productivity and effi ciency of the swine industry through application of future knowledge of chemical sensing by the gut. We propose that focusing on the chemosensory system that lines the epithelium of the GI tract of pigs may provide venues to infl uence gut-gut or gut-brain signaling cascades that ultimately can be helpful to improve animal health and/or performance. We identify 5 general mechanisms through which knowledge of chemosensing may lead to practical progress in pig production: trophic effects, barrier function, feed intake, insulin action, and fermentation products. Key mediators, such as the GLP, are involved in several of these mechanisms; an increase in GLP is benefi cial across several areas of concern (e.g., trophic effects, barrier function) but in others (e.g., feed intake), an increase may be detrimental. Practical application would likely be achieved through dietary changes, but separate management factors, drugs, or other interventions may also be developed.
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